换一批Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.
第一作者：
Gail D Lewis,Phillips
第一单位：
Authors' Affiliations: Research Oncology, Departments of Biostatistics, Product Development Oncology, and Translational Oncology, Genentech, Inc., South San Francisco, California; Indiana University Simon Cancer Center, Indianapolis, Indiana; Institute Gustave Roussy, Villejuif; Department of Medical Oncology, Institut Curie, Paris, France; Sarah Cannon Research Institute, Nashville, Tennessee; Loyola University Medical Center, Maywood, Illinois; University of Munich, Munich, Germany; and Division of Medical Oncology, Centro di Riferimento Oncologico, Instituto Nazionale Tumori Aviano, Italy.
作者：
医学主题词
动物(Animals);自身分泌性细胞间通讯(Autocrine Communication);乳腺肿瘤(Breast Neoplasms);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);疾病模型, 动物(Disease Models, Animal);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);人类(Humans);小鼠(Mice);神经调节蛋白1(Neuregulin-1);神经调节蛋白类(Neuregulins);信号传导(Signal Transduction);治疗结果(Treatment Outcome);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1158/1078-0432.CCR-13-0358
PMID
24097864
发布时间
2022-03-10
- 浏览32
Clinical cancer research
456-68页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
